Luwy Musey

6PUBLICATIONS
5CO-AUTHORS
Epidemiological modellingPacific Peoples epidemiologyAdolescent healthPacific Peoples mothers and babies health and wellbeingPacific Peoples health promotion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 11, 2022
Immunogenicity, Safety, and Tolerability of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Immunocompetent Adults Aged 18-49 Years With or Without Risk Factors for Pneumococcal Disease: A Randomized Phase 3 Trial (PNEU-DAY).

Laura L Hammitt, Dean Quinn, Ewa Janczewska

|Nov 02, 2021
Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU).

Randall Severance, Howard Schwartz, Ron Dagan

|Oct 21, 2021
Matching-adjusted indirect comparison of pneumococcal vaccines V114 and PCV20.

Shahrul Mt-Isa, Lauren A Abderhalden, Luwy Musey

|May 21, 2021
Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older.

Ulrike K Buchwald, Charles P Andrews, John Ervin

|Feb 11, 2021
Immunogenicity following revaccination or sequential vaccination with 23-valent pneumococcal polysaccharide vaccine (PPSV23) in older adults and those at increased risk of pneumococcal disease: a review of the literature.

Allan W Cripps, Temitope Folaranmi, Kelly D Johnson

|Jan 22, 2021
Efficacy and effectiveness of a 23-valent polysaccharide vaccine against invasive and noninvasive pneumococcal disease and related outcomes: a review of available evidence.

Michael S Niederman, Temitope Folaranmi, Ulrike K Buchwald

Pageof 1

Frequent Collaborators

4 joint publications

Ulrike K Buchwald

2 joint publications

Ron Dagan

1 joint publications

Jon E Stek

1 joint publications

Randall Severance